Loading
Clover Health Investments, CORP. /de Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Loengard Anna U, was filed 14 Aug 2025.
Insider Decl.
390
Thresholds
n/a
Buy Volume
€12M
16 ops. · all time
Sell Volume
€9M
53 ops. · all time
Who traded when
BuySaleJamie L. Reynoso25 sales
Conrad Wai7 sales
Karen Soares7 sales
Andrew Toy5 sales
Joseph Clay Thornton3 sales
Oldakowski Joseph Frank3 sales
+4 other insiders
Since the insiders bought
- +61.1%Entry US$2.65 · Close at T+365 US$4.27
- +85.0%Entry US$2.47 · Close at T+365 US$4.57
- -70.0%Entry US$3.13 · Close at T+365 US$0.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,165 of 26,280 companies
23.7
score / 100
Value26
Quality22
FCF yld-2.7%
Earn yld-3.4%
EV/EBITDA·
ROE-5.1%
Gross mgn18%
Net mgn-4.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2023FY ended December 2023 · cache
US$4.78
Analyst consensus
4 analysts2.00/5
US$5.00Target US$5.38(+12%)US$6.00
Income statement
RevenueUS$1.9B
Gross profitUS$355.9M18% margin
EBITDA-US$83.9M-4% margin
Net income-US$85.5M-0.7% margin
Valuation
PER (forward)31.9x
P/Book6.7x
Beta2.46
Balance sheet & cash
Market capUS$2.5B
Total debtUS$4.7M
Free Cash Flow-US$69M
Profitability & ownership
ROE-5.1%
ROA-1.8%
% insiders4.2%
% institutions33.9%
Last declaration on 20 October 2026
Declarations390 total
19,275 shares@ US$4.440.0036% mcap26.8% of flowCommonSEC144:0001950047-26-010329
4,066 shares@ US$4.410.0008% mcap0.6% of flowClass A Common StockSEC:0001839066-26-000057:0
19,275 shares@ US$4.660.0038% mcap3.6% of flowClass A Common StockSEC:0001999086-26-000034:0
4,066 shares@ US$4.480.0008% mcap15.9% of flowCommonSEC144:0001950047-26-010309
62,176 shares@ US$4.680.012% mcap2.0% of flowClass A Common StockSEC:0001801170-26-000284:0
4,591 shares@ US$4.680.0009% mcap17.0% of flowClass A Common StockSEC:0001801170-26-000280:0
14,673 shares@ US$4.680.0029% mcap2.8% of flowClass A Common StockSEC:0001801170-26-000282:0
23,627 shares@ US$4.680.0047% mcap1.7% of flowClass A Common StockSEC:0001801170-26-000278:0
18,273 shares@ US$4.680.0036% mcap3.0% of flowClass A Common StockSEC:0001801170-26-000276:0
17,858 shares@ US$4.680.0033% mcap28.9% of flowClass A Common StockSEC144:0001801170-26-000265
14,341 shares@ US$4.680.0026% mcap100.0% of flowClass A Common StockSEC144:0001801170-26-000266
23,463 shares@ US$4.680.0043% mcap50.5% of flowClass A Common StockSEC144:0001801170-26-000267
60,765 shares@ US$4.680.011% mcap7.3% of flowClass A Common StockSEC144:0001801170-26-000269
4,487 shares@ US$4.680.0008% mcap18.8% of flowClass A Common StockSEC144:0001801170-26-000268
2,006 shares@ US$4.600.0004% mcap9.6% of flowCommonSEC144:0001950047-26-010102
2,006 shares@ US$4.630.0004% mcap0.3% of flowClass A Common StockSEC:0001839066-26-000054:0
8,706 shares@ US$4.680.0018% mcap19.8% of flowClass A Common StockSEC144:0001839066-26-000050
8,750 shares@ US$4.420.0017% mcap1.4% of flowClass A Common StockSEC:0001839066-26-000052:0
12,481 shares0Class A Common StockSEC:0001801170-26-000244:0
12,481 shares0Class A Common StockSEC:0001801170-26-000243:0
318,806 shares@ US$4.190.058% mcap10.2% of flowClass A Common StockSEC:0001801170-26-000242:0
309,558 shares@ US$4.230.057% mcap36.0% of flowClass A Common StockSEC144:0001838733-26-000031
141,418 shares@ US$4.46310.026% mcap10.2% of flowCommonSEC144:0001950047-26-009783
1,921 shares@ US$4.560.0004% mcap0.3% of flowClass A Common StockSEC:0001839066-26-000047:0
1,921 shares@ US$4.560.0004% mcap8.9% of flowCommonSEC144:0001950047-26-009622
25 of 390 declarations
About Clover Health Investments, CORP. /de
A single purchase dominates the Clover Health Investments (Healthcare & Pharma) record: EUR 8,868,597 by Chamath Palihapitiya, a holder of more than 10%, on November 22, 2021. The 16 purchases total EUR 12,219,230 (median EUR 45,747). Director Vivek Garipalli bought EUR 931,437 on June 17, 2024 and EUR 915,740 on August 9, 2024. From August 7 to August 13, 2025, 2 filers bought EUR 914,251 worth.
The 53 sales amount to EUR 9,115,340, with a median of EUR 42,944; purchases make up 23% of open-market trades. The three largest sales all date from 2026: Andrew Toy (Chief Executive Officer) EUR 1,465,718 on July 1 and EUR 1,178,307 on October 1, Conrad Wai (CEO, Counterpart Health) EUR 1,226,822 on September 15.
Read moreShow less
The record gathers 390 filings from 38 filers, including 262 grants and 16 option exercises. Jamie L. Reynoso (CEO, Medicare Advantage) files 93, Karen Soares 45. The pace rises year after year, from 15 filings in 2021 to 117 in 2026. The last twelve months hold 134, with 40 sales and no purchase. The 16 purchases tracked at 90 days show a median of 8.1% with 56% of cases positive, recorded past results, not a forecast.
